Stem cells can be classified both on the basis of their differentiation capacity and on their origin. Based on their origin, the following are recognized.
MSCs are currently widely used both for their regenerative and immunomodulatory capabilities. In fact, they are able to migrate to affected areas by attracting other cells and supporting their differentiation.
The Italian legislation in this regard (agreement 17 October 2013), requires that the products of cell therapy are exclusively autologous (the initial sample and the finished product must derive and be administered to the same animal), and that they are prepared by qualified personnel with proven experience about.
These are just some of the possible applications for cell therapy, but the potential represented by this product of regenerative medicine opens the door to other lines of research as evidenced by the scientific literature.
Voga M, Adamic N, Vengust M and Majdic G (2020) Stem Cells in Veterinary Medicine—Current State and Treatment Options. Front. Vet. Sci. 7:278. doi: 10.3389/fvets.2020.00278
Jessica M. Quimby, Stem Cell Therapy, Veterinary Clinics of North America: Small Animal Practice, Volume 49, Issue 2, 2019, Pages 223-231, ISSN 0195-5616, ISBN 9780323678483, https://doi.org/10.1016/j.cvsm.2018.10.001.
Voga M, Adamic N, Vengust M, Majdic G. Stem Cells in Veterinary Medicine-Current State and Treatment Options. Front Vet Sci. 2020 May 29;7:278. doi: 10.3389/fvets.2020.00278. PMID: 32656249; PMCID: PMC7326035
Per maggiori informazioni, compilare il seguente modulo. Sarete ricontattati nel più breve tempo possibile
For further informations, please fill in the form. You will be contacted as soon as possibile.